These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 6334489)
1. [Substrate specificity of the beta-lactamases found in a number of clinical strains of gram-negative bacteria]. Sazykin AIu; Navashin SM Antibiotiki; 1984 Sep; 29(9):657-61. PubMed ID: 6334489 [TBL] [Abstract][Full Text] [Related]
2. [Characteristics of the substrate specificity of the crude endogenous beta-lactamases of gram-negative bacteria]. Bibikova MV; Ivanitskaia LP; Nikishina VG; Kuznetsova SM Antibiotiki; 1983 Aug; 28(8):566-73. PubMed ID: 6416154 [TBL] [Abstract][Full Text] [Related]
3. Classification of beta-lactamases. Bauernfeind A Rev Infect Dis; 1986; 8 Suppl 5():S470-81. PubMed ID: 3541132 [TBL] [Abstract][Full Text] [Related]
4. [Detection of AmpC beta-lactamases in Gram-negative bacteria isolated from urine]. Cernohorská L; Andrysík T Epidemiol Mikrobiol Imunol; 2008 Nov; 57(4):141-6. PubMed ID: 19069027 [TBL] [Abstract][Full Text] [Related]
5. Characteristics, epidemiology and clinical importance of emerging strains of Gram-negative bacilli producing extended-spectrum beta-lactamases. Shah AA; Hasan F; Ahmed S; Hameed A Res Microbiol; 2004; 155(6):409-21. PubMed ID: 15249058 [TBL] [Abstract][Full Text] [Related]
6. Extended-spectrum beta-lactamases: an actual problem of hospital microbiology (a review). Szabó D; Barcs I; Rozgonyi F Acta Microbiol Immunol Hung; 1997; 44(4):309-25. PubMed ID: 9554165 [TBL] [Abstract][Full Text] [Related]
7. Evaluation of the MicroScan ESBL plus confirmation panel for detection of extended-spectrum beta-lactamases in clinical isolates of oxyimino-cephalosporin-resistant Gram-negative bacteria. Stürenburg E; Lang M; Horstkotte MA; Laufs R; Mack D J Antimicrob Chemother; 2004 Nov; 54(5):870-5. PubMed ID: 15471997 [TBL] [Abstract][Full Text] [Related]
9. [Resistance to newer beta-lactams and related ESBL types in gram-negative nosocomial isolates in Turkish hospitals: results of the multicentre HITIT study]. Gür D; Gülay Z; Akan OA; Aktaş Z; Kayacan CB; Cakici O; Eraç B; Gültekin M; Oğünç D; Söyletir G; Unal N; Uysal S Mikrobiyol Bul; 2008 Oct; 42(4):537-44. PubMed ID: 19149074 [TBL] [Abstract][Full Text] [Related]
10. [Broad-spectrum beta-lactamases in Gram-negative bacteria]. Sundsfjord A; Simonsen GS; Haldorsen B; Lundblad EW; Samuelsen O Tidsskr Nor Laegeforen; 2008 Dec; 128(23):2741-5. PubMed ID: 19079424 [TBL] [Abstract][Full Text] [Related]
11. Multidrug resistance in Gram-negative bacteria that produce extended-spectrum beta-lactamases (ESBLs). Giamarellou H Clin Microbiol Infect; 2005 Jul; 11 Suppl 4():1-16. PubMed ID: 15953019 [TBL] [Abstract][Full Text] [Related]
12. [Beta-lactamases with a wide substrate spectrum in gram negative strictly anaerobic rods]. Rokosz A; Sawicka-Grzelak A; Kot K; Pituch H; Meisel-Mikołajczyk F; Luczak M Med Dosw Mikrobiol; 2000; 52(2):129-37. PubMed ID: 11107787 [TBL] [Abstract][Full Text] [Related]
13. Current challenges in antimicrobial chemotherapy: the impact of extended-spectrum beta-lactamases and metallo-beta-lactamases on the treatment of resistant Gram-negative pathogens. Helfand MS; Bonomo RA Curr Opin Pharmacol; 2005 Oct; 5(5):452-8. PubMed ID: 16084766 [TBL] [Abstract][Full Text] [Related]
16. [Determination of beta-lactamase types of clinical strains of bacteria using a modified microiodometric method]. Sazykin AIu; Krylov AS; Vakulenko SB; Abadzhieva AN; Nikishina VG Antibiotiki; 1984 Jun; 29(6):413-7. PubMed ID: 6433785 [TBL] [Abstract][Full Text] [Related]
17. Investigation of the presence of different broad-spectrum beta-lactamases among clinical isolates of Enterobacteriacae. Nagy E; Pragai Z; Kóczián Z; Hajdú E; Fodor E Acta Microbiol Immunol Hung; 1998; 45(3-4):433-46. PubMed ID: 9873949 [TBL] [Abstract][Full Text] [Related]